Significant elevation of tyrosine has been identified in individuals with metabolic disorders [ 44 ] and had highly significant associations with future diabetes [ 45 ].
← all excerpts
Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial.
1
—
—